Herz- & Kreislauferkrankungen

This book is a comprehensive overview of heart failure and cardiac transplantation and integrates scientific and clinical information about the physiology, pathophysiology, diagnosis, and treatment of this disorder. Organized into five parts, it reviews the history and basic mechanisms of heart failure; etiology of heart failure; heart failure disease progression; advanced therapies for heart failure; and cardiac transplantation. The book presents basic concepts in the physiology, molecular biology, pathology, and epidemiology of the normal and failing heart; known causes of heart failure, such as right heart failure, valvular cardiomyopathy, molecular mechanisms of sarcomeric cardiomyopathies, and neuromuscular cardiomyopathy; cardiorenal syndrome; neurohormonal activation; cardiac resynchronization, ventricular assist devices; regenerative mechanisms; orthotopic heart transplantation; early and late management of the post-transplant patient; heart transplantation and antibody-mediated rejections; heart-lung transplantation; and cardiac xenotransplantation.Featuring contributions from leaders in the fields of heart failure, cardiac transplantation, cardiac pathology, and cardiovascular molecular research, Congestive Heart Failure and Cardiac Transplantation is a valuable compendium for cardiologists, cardiothoracic surgeons, researchers, trainees, and students.

Was passiert eigentlich, wenn unser Herz vor Freude einen Satz macht? Und wenn wir Herzfl attern bekommen? Oder uns jemand das Herz bricht? Felix Schröder, angehender Kardiologe, fühlt unserem wichtigsten Organ auf den Zahn und beantwortet all diese und noch viele weitere Fragen zu unserem Herzen. Zusammen mit Nina Weber erklärt er außerdem, was eigentlich die Unter schiede zwischen Männer- und Frauen herzen sind, warum Babyherzen wahre Champions sind und wie wir alle uns besser um unsere Herzen kümmern können. Eine Herzensangelegenheit - nicht nur für Romantiker!

Paperback

Some of the leading scientists in the field of hypertension accepted an invi­ tation to actively participate in an international symposium on primary hypertension. Scientists from 13 countries - from western, southern, and eastern Europe, Australia, and the United States - were present. The meeting was held in Cologne in March 1985. After previous meetings and workshops at Titisee in the Black Forest and several symposia on the renin­ angiotensin-aldosterone system here in Cologne, this symposium on prima­ ry hypertension was organized in order to induce and to stimulate critical discussion on the basic pathogenetic mechanisms involved and the recently established therapeutic implications. Numerous studies have been based on the concept that the elevation in blood pressure is mediated by several vasopressor substances. For this reason the renin-angiotensin system has been considered to be the essential endocrine mechanism involved in developing and sustaining arterial hyper­ tension. Other vasopressor factors, such as catecholamines, vasopressin, and serotonin, have been studied extensively and were assumed to play additional parts in blood pressure regulation. However, several other ap­ proaches have been initiated in recent years.